Evidence map›Paper›PMID 34302213›Full record

ArticleVirchows Archiv : an international journal of pathology2021

Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis.

Yukihiro Wada, Masayuki Iyoda, Taihei Suzuki, Shohei Tachibana, Nobuhiro Kanazawa, Kei Matsumoto, Hirokazu Honda

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Repeat biopsies in membranous lupus nephritis in the era of target antigen identification.Virchows Archiv : an international journal of pathology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yukihiro Wada *Department of Medicine, Division of Nephrology, Showa University School of Medicine, Tokyo, Japan.
Masayuki Iyoda *Department of Medicine, Division of Nephrology, Showa University School of Medicine, Tokyo, Japan. iyoda@med.showa-u.ac.jp.ORCID http://orcid.org/0000-0002-1153-3000
Taihei SuzukiDepartment of Medicine, Division of Nephrology, Showa University School of Medicine, Tokyo, Japan.
Shohei TachibanaDepartment of Medicine, Division of Nephrology, Showa University School of Medicine, Tokyo, Japan.
Nobuhiro KanazawaDepartment of Medicine, Division of Nephrology, Showa University School of Medicine, Tokyo, Japan.
Kei MatsumotoDepartment of Medicine, Division of Nephrology, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Hirokazu HondaDepartment of Medicine, Division of Nephrology, Showa University School of Medicine, Tokyo, Japan.
Showa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exostosin 1 and exostosin 2 (EXT1/EXT2) on glomerular basement membrane (GBM) were recently reported as novel putative antigens in secondary membranous nephropathy with autoimmune disease. However, the clinical significance of glomerular EXT1/EXT2 remains elusive in patients with lupus nephritis (LN). The immunofluorescence staining pattern of glomerular EXT1/EXT2 is also undetermined in membranous LN (MLN) or proliferative LN (PLN). We cross-sectionally analyzed patients with MLN (pure class V, n = 11) and PLN (class III, IV, and mixed class III/IV + V, n = 22) who underwent renal biopsies between 2010 and 2020 at Showa University Hospital. Glomerular EXT1/EXT2 expressions were evaluated by immunofluorescence. T-helper (Th) cell-related serum inflammatory cytokines were measured using enzyme-linked immunosorbent assay. The positivity for both EXT1/EXT2 was higher in patients with MLN than PLN (90.9% vs 63.6%, P = 0.212). MLN showed global and bright granular EXT1/EXT2 expressions along GBM, while PLN showed segmental and moderate expressions on GBM. Additionally, glomerular EXT1/EXT2 positivity was not associated with the degree of proteinuria or renal function in MLN and PLN patients, but the levels of serum anti-dsDNA antibody and circulating immune complexes were lower in patients with EXT1/EXT2-positive MLN than EXT1/EXT2-negative PLN. Moreover, serum complement levels and IL-4/IFN-γ ratios were elevated in EXT1/EXT2-positive MLN than EXT1/EXT2-negative PLN. Collectively, immunofluorescence staining for glomerular EXT1/EXT2 had characteristic patterns between MLN and PLN. Glomerular EXT1/EXT2 expressions tended to be high in Th2-dominant MLN patients without severe hypocomplementemia and elevated autoantibodies. Thus, EXT1/EXT2 might be involved in the unique developmental mechanism of MLN.

Indexed as

ImmunohistochemistryAdultAntibodies, AntinuclearAntigen-Antibody ComplexBiomarkersBiopsyCross-Sectional StudiesCytokinesExostosin 1Exostosin 2FemaleHumansInflammation MediatorsJapanKidney GlomerulusLupus NephritisAntibodies, AntinuclearAntigen-Antibody ComplexBiomarkersCytokinesExostosin 1Exostosin 2Inflammation MediatorsN-AcetylglucosaminyltransferasesExostosin 1Exostosin 2Membranous lupus nephritisProliferative lupus nephritisT-helper type 2

Identifiers

PMID34302213
OpenAlexW3185446685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.